Skip to content
Play Modern Today

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Package Over Information Apprehensions

Health funding illustration
The proposed American financial assistance would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a substantial American healthcare agreement valued at $367m (£272m) spanning five years over Washington's insistence on sensitive biological samples.

The decision became public after a government memo from December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government spokesman has since clarified that the United States was seeking health data for scientific study and commercial purposes but was not willing to share the benefits from future treatments.

"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged continued dialogue to find a deal suitable to all parties so the country's critical HIV treatment initiative can continue.

Broader Background

This rejection comes after a similar situation in Kenya, where a court suspended a similar health funding agreement after legal challenges were filed about the security of citizens' health data.

Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

USAID had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.

As per statements, Sixteen nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"Our nation was requested to share its genetic material and health information over an extended period, without any corresponding promise of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.

"Effectively, our country would supply the basic resources for medical research with no assurance that the end products would be accessible to our citizens should a new health crisis emerge."

Sovereignty and Global Health

He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting structures already established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.

"This system is intended to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage ongoing discussions with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and interests of each country."

Medical Community Reaction

A leading public health body said it acknowledged the government's concerns, but recommended that talks must proceed considering much of the country's Aids initiatives were funded by international support.

"Where specific concerns exist, including those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it added.

This impasse underscores the continuing challenges between accepting vital international aid and safeguarding a country's data in an ever more data-driven world.

By

Kimberly Mcgrath

A passionate gaming journalist and tech enthusiast with over a decade of experience covering modern gaming trends and innovations.

Play Modern Today

Type to search articles.